The store will not work correctly when cookies are disabled.
US9169234, 17
ID: ALA3971928
PubChem CID: 52911381
Max Phase: Preclinical
Molecular Formula: C14H18N2O4S
Molecular Weight: 310.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COCC(=O)NCCc1c[nH]c2ccc(S(C)(=O)=O)cc12
Standard InChI: InChI=1S/C14H18N2O4S/c1-20-9-14(17)15-6-5-10-8-16-13-4-3-11(7-12(10)13)21(2,18)19/h3-4,7-8,16H,5-6,9H2,1-2H3,(H,15,17)
Standard InChI Key: ZQUAKJBUKQFQSY-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
-2.0979 -11.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2966 -10.5966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7622 -9.1698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7600 -8.0526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4141 -8.3003 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2256 -6.6258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2234 -5.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6890 -4.0818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5988 1.5004 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.5996 2.7004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6378 0.9001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6383 2.0999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
4 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 9 1 0
17 12 1 0
15 18 1 0
18 19 2 0
18 20 2 0
18 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 310.38 | Molecular Weight (Monoisotopic): 310.0987 | AlogP: 0.88 | #Rotatable Bonds: 6 |
Polar Surface Area: 88.26 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: -0.03 | CX LogD: -0.03 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.83 | Np Likeness Score: -1.49 |
References
1. (2015) Sepiapterin reductase inhibitors for the treatment of pain, |